Authors: Neve, RM Lane, HA Hynes, NE

Citation: Rm. Neve et al., The role of overexpressed HER2 in transformation, ANN ONCOL, 12, 2001, pp. 9-13

Authors: Neve, RM Nielsen, UB Kirpotin, DB Poul, MA Marks, JD Benz, CC

Citation: Rm. Neve et al., Biological effects of anti-ErbB2 single chain antibodies selected for internalizing function, BIOC BIOP R, 280(1), 2001, pp. 274-279

Authors: Neve, RM Sutterluty, H Pullen, N Lane, HA Daly, JM Krek, W Hynes, NE

Citation: Rm. Neve et al., Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells, ONCOGENE, 19(13), 2000, pp. 1647-1656

Authors: Lane, HA Beuvink, I Motoyama, AB Daly, JM Neve, RM Hynes, NE

Citation: Ha. Lane et al., ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: Receptor overexpression does not determine growth dependency, MOL CELL B, 20(9), 2000, pp. 3210-3223

Authors: Olayioye, MA Neve, RM Lane, HA Hynes, NE

Citation: Ma. Olayioye et al., The ErbB signaling network: receptor heterodimerization in development andcancer, EMBO J, 19(13), 2000, pp. 3159-3167

Authors: Croxford, JL Triantaphyllopoulos, KA Neve, RM Feldmann, M Chernajovsky, Y Baker, D

Citation: Jl. Croxford et al., Gene therapy for chronic relapsing experimental allergic encephalomyelitisusing cells expressing a novel soluble p75 dimeric TNF receptor, J IMMUNOL, 164(5), 2000, pp. 2776-2781